Monday, February 13, 2012

Risperdal Trial: Plaintiff's Lawyer claims that J&J Hid Risperdal Studies to Boost Drug Sales

From Bloomberg:

J and J  hid studies showing its Risperdal anti-psychotic drug caused diabetes to protect billions of dollars in sales, a lawyer said in the first personal-injury claim over the medication to go to trial. Researchers at J&J’s Janssen unit knew as early as 1999 that a study found Risperdal caused diabetes at a higher rate than a competing drug and failed to hand over the results to regulators probing links between the disease and anti-psychotic medicines.